Canopy Launches Brazil Joint Venture

Katelyn Baker

Well-Known Member
Cannabis firm Canopy Growth Corporation (CVE:CGC) has agreed a deal with São Paulo-based Entourage Phytolab to develop medicinal products in Brazil.

The deal will see the two firms work together to develop innovative cannabis-based medical products for the Brazilian and international markets.

"Brazil represents a large emerging market, and has a favourable regulatory framework for medical cannabis products as well as competitive clinical trial and production costs," said Canopy chairman and chief executive Bruce Linton.

Entourage already has permission from ANVISA — the Brazlian health surveillance agency — for the research and development of cannabis-based therapeutics.

The JV will take on the name Bedrocan Brazil as Canopy already has a North American subsidiary called Bedrocan Canada.

The agreement will allow the JV to hold the exclusive local rights to use the "world-leading" Bedrocan brand.

Canopy says that Bedrocan Brazil will import cannabis products from Canada or the Netherlands initially, with a view to establishing domestic cultivation facilities in Brazil in the future.

cannabiss1.jpg


News Moderator: Katelyn Baker 420 MAGAZINE ®
Full Article: Canopy Launches Brazil Joint Venture
Author: Tom Howard
Contact: 416 451 6521
Photo Credit: None Found
Website: Proactive Investors
 
Back
Top Bottom